Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant

Journal of Experimental Medicine

Volumn 188, Issue 11, 1998, Pages 2075-2082

  Pulendran, Bali ^a,c   Smith, J L ^a   Jenkins, M ^b   Schoenborn, M ^a   Maraskovsky, E ^a   Maliszewski, C R ^a  

^a AMGEN INC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

Adjuvant; Dendritic cells; Flt3 ligand; Immunity; Tolerance

Indexed keywords

ADJUVANT; CD40 ANTIGEN; FLT3 LIGAND; GROWTH FACTOR; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD40; CELL COMMUNICATION; DENDRITIC CELLS; IMMUNE TOLERANCE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 0031774897     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.11.2075     Document Type: Article

References (40)

1. Burnet, F.M. 1957. A modification of Jerne's theory of antibody production using the concept of clonal selection. Austr. J. Sci. 20:67-69.
2. Dresser, D.W. 1962. Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen. Immunology. 5:131-138.
3. Mitchison, N.A. 1964. Induction of immunological paralysis in two zones of dosage. Proc. R. Soc. Biol. 161:275-292.
4. Chiller, J.M., G.S. Habicht, and W. Weigle. 1971. Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science. 171:813-815.
5. Nossal, G.J.V. 1983. Cellular mechanisms of immunological tolerance. Annu. Rev. Immunol. 1:33-62.
6. Burstein, H.J., and A. Abbas. 1993. In vivo role of IL-4 in T cell tolerance induced by aqueous protein antigen. J. Exp. Med. 177:457-463.
7. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science. 248:1349-1356.
8. Kearney, E.R., K.A. Pape, D.Y. Loh, and M.K. Jenkins. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity. 1:327-339.
9. Pape, K.A., A. Khoruts, A. Mondino, and M. Jenkins. 1997. Inflammatory cytokines enhance expansion and differentiation of antigen-activated CD4+ T cells. J. Immunol. 159: 591-598.
10. Van Parijs, L., and A.K. Abbas. 1998. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:243-248.
11. Enyon, E.E., and D.C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131-138.
12. Fuchs, E.J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science. 258:1156-1159.
13. Matzinger, P. 1994. Tolerance, danger and the extended family. Annu. Rev. Immunol. 12:991-1045.
14. Zhong, G., C. Reis e Sousa, and R.N. Germain. 1997. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186:673-682.
15. Warren, H.S., F.R. Vogel, and L.A. Chedid. 1986. Current status of immunologic adjuvants. Annu. Rev. Immunol. 4:369-391.
16. Liu, Y., and C.A. Janeway. 1991. Microbial induction of co-stimulatory activity for CD4 T-cell growth. Int. Immunol. 3:323-332.
17. Parks, D.E., S.M. Walker, and W. Weigle. 1981. Bacterial lipopolysaccharide (endotoxin) interferes with the induction of tolerance and primes thymus-derived lymphocytes. J. Immunol. 126:938-948.
18. Steinman, R.M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
19. Banchereau, J., and R.M. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
20. Inaba, K., M. Witmer-Pack, M. Inaba, K.S. Hathcock, H. Sakuta, M. Azuma, H. Yagita, K. Okumura, P.S. Linsley, S. Ikehara, et al. 1994. The tissue distribution of the B7-2 co-stimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
21. Maraskovsky, E., K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K.D. Shortman, and H.J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953-1961.
22. Pulendran, B., J. Lingappa, M.K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C.R. Maliszewski, and E. Maraskovsky. 1997. Developmental pathways of dendritic cells in vivo. J. Immunol. 159:2222-2231.
23. lo thymocytes in vivo. Science. 250:1720-1723.
24. Haskins, K., R. Kubo, J. White, M. Pigeon, J. Kappler, and P. Marrack. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157:1149-1169.
25. 24a. Spriggs, M.K., B.H. Koller, T. Sato, P.J. Morrissey, W.C. Fanslow, O. Smithies, M.B. Voice, M.B. Widmer, and C.R. Maliszewski. 1992. β-2 microglobulin-, CD8+ T cell-deficient mice survive inoculation with high doses of vaccinia virus and altered IgG responses. Proc. Natl. Acad. Sci. USA. 89: 6070-6075.
26. Khoruts, A., A. Mondino, K.A. Pape, S.L. Reiner, and M. Jenkins. 1998. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J. Exp. Med. 187:225-236.
27. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Shuler. 1996. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741-746.
28. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:747-752.
29. Stout, R.D., and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today. 17: 487-492.
30. Grewal, I.S., and R.A. Flavell. 1996. A central role for CD40 ligand in the regulation of CD4+ T cell responses. Immunol. Today. 17:410-414.
31. Renshaw, B.R., W.B. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
32. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliot, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
33. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
34. Castigli, E., F.W. Alt, L. Davidson, A. Bottaro, E. Mizoguchi, A.K. Bahn, and R.S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA. 91:12135-12139.
35. Lynch, D.H., A. Andreasen, E. Maraskovsky, J. Whitmore, R.E. Miller, and J.C.L. Schuh. 1997. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med. 3:625-631.
36. Steptoe, R.J., F. Fumin, L. Wei, M.L. Drakes, L. Lina, A.J. Demetris, S. Qian, H.J. McKenna, and A.W. Thomson. 1997. Augmentation of dendritic cell in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159:5483-5491.
37. Gong, J., D. Chen, M. Kashiwaba, Y. Li, L. Chen, H. Takeuchi, H. Qu, J.R. Rowse, S.J. Gendler, and D. Kufe. 1998. Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells. Proc. Natl. Acad. Sci. USA. 95:6279-6283.
38. Viney, J.L., A.M. Mowat, J.M. O'Malley, E. Williamson, and N.A. Fanger. 1998. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160:5815-5825.
39. Khoury, S.J., O. Lider, A. Sabbagh, and H.L. Weiner. 1990. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. Cell. Immunol. 131:302-310.
40. Perez, V.L., L. Van Parijs, A. Biuckians, X.X. Zheng, T.B. Strom, and A.K. Abbas. 1997. Induction of peripheral T-cell tolerance in vivo requires CTLA-4 engagement. Immunity. 6:411-417.